Latest Features & Opinion

Live Coverage of AHS 2017

Stay with Neurology Advisor for the latest updates from the 2017 American Headache Society Annual Meeting, taking place in Boston, June 8-11.

Live Coverage of MDS 2017

Neurology Advisor brings you live coverage of the 2017 International Congress of Parkinson's Disease and Movement Disorders from Vancouver, BC, Canada.

Genetic Tx Targets for Rare Migraine ...

There is up to a 4-fold increase in risk in people with a first-degree relative affected by migraines, and twin studies have demonstrated heritability of approximately 42%.

CMSC 2017 Annual Meeting Coverage

Coverage of the 2017 Consortium of Multiple Sclerosis Centers Annual Meeting, taking place May 24-27 in New Orleans, LA.

Guidelines: Preventing Brain Injury After CPR

For survivors of nontraumatic cardiac arrest, brain injury becomes a major factor in disability and long-term survival.

New Clinical Guidelines: Progressive Supranuclear Palsy

New guidelines for progressive supranuclear palsy provide very specific and sensitive criteria that allow for identification of clinical features of the disease at much earlier stages.

AVM-Associated Headache: Etiology and Treatment

Several mechanisms involving trigeminovascular activation are often proposed in the literature as mechanisms underlying nonhemorrhagic headache in patients with AVM.

Steps for Improving Stroke Diagnosis

Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.

Impulse Control Disorders in Parkinson’s

A patient should be notified of the possibility of developing an ICD before initiating any dopaminergic treatment for PD, particularly dopamine agonists.

Migraine Across Female Reproductive Stages

The characteristics of migraine may change throughout a woman's reproductive stages, and may require different treatment strategies.
Practice Management

Challenges of Medical Liability Reform

Challenges of Medical Liability Reform

A hostile medical litigation climate is one of the major problems with the existing malpractice insurance system, driving significant losses of access to quality health care.

Concerns Arise Over Reporting of Negative Clinical Trial Data

Concerns Arise Over Reporting of Negative Clinical Trial Data

The main objection to nonreporting of negative results is that it contributes to a body of knowledge that is at best, incomplete, and at worst, wrong.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorder

Questioning Special Diets, Supplements for Autism

All of the studies were small, including anywhere from 12 to 92 children, and they typically lasted less than 6 months.

Early Intervention May Benefit Those At-Risk for Autism

Infants at risk for autism do better if therapists train parents to communicate more effectively.

FDA Warns of Reported Autism Treatments, Cures

The FDA has warned and/or taken action against a number of companies that have made improper claims about the intended use of their products to treat or cure autism.

Latest in Neuromuscular Disorders

New Amyotrophic Lateral Sclerosis Tx Approved by FDA

Radicava is the first approved treatment for ALS in over 20 years.

RENEW Trial: Promising Results for Optic Neuritis Treatment

Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.

FDA Approves Duchenne Muscular Dystrophy Drug

Emflaza is approved for the treatment of Duchenne muscular dystrophy regardless of genetic etiology.

Sign Up for Free e-newsletters